Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Prokidney (PROK) Return on Sales (2022 - 2025)

Historic Return on Sales for Prokidney (PROK) over the last 4 years, with Q3 2025 value amounting to 165.18%.

  • Prokidney's Return on Sales fell 456905100.0% to 165.18% in Q3 2025 from the same period last year, while for Sep 2025 it was 214.04%, marking a year-over-year decrease of 457393700.0%. This contributed to the annual value of 2149.14% for FY2024, which is N/A changed from last year.
  • According to the latest figures from Q3 2025, Prokidney's Return on Sales is 165.18%, which was down 456905100.0% from 167.26% recorded in Q2 2025.
  • In the past 5 years, Prokidney's Return on Sales ranged from a high of 45525.33% in Q3 2024 and a low of 637.93% during Q4 2024
  • For the 4-year period, Prokidney's Return on Sales averaged around 10294.7%, with its median value being 7241.33% (2023).
  • Its Return on Sales has fluctuated over the past 5 years, first surged by 245298300bps in 2024, then tumbled by -456905100bps in 2025.
  • Over the past 4 years, Prokidney's Return on Sales (Quarter) stood at 12286.5% in 2022, then tumbled by -41bps to 7241.33% in 2023, then tumbled by -109bps to 637.93% in 2024, then soared by 74bps to 165.18% in 2025.
  • Its Return on Sales stands at 165.18% for Q3 2025, versus 167.26% for Q2 2025 and 165.01% for Q1 2025.